Marco Merlano

10PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 13, 2026
Does Glucose-6-Phosphate Dehydrogenase Deficiency Correlate with Increased Sensitivity to Cisplatin? A Case Report and a Narrative Literature Review.

|Jan 08, 2025
Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review.

Ornella Garrone, Fiorella Ruatta, Carmen Giusy Rea

|Nov 14, 2023
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.

Marco Carlo Merlano, Matteo Paccagnella, Nerina Denaro

|Feb 28, 2023
Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib.

Andrea Abbona, Vincenzo Ricci, Matteo Paccagnella

|Dec 23, 2022
Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience.

Nerina Denaro, Ornella Garrone, Michele Ghidini

|Nov 26, 2022
The Role of Cytokinome in the HNSCC Tumor Microenvironment: A Narrative Review and Our Experience.

Nerina Denaro, Cinzia Solinas, Ornella Garrone

Pageof 2

Frequent Collaborators

8 joint publications

Ornella Garrone

7 joint publications

Nerina Denaro

5 joint publications

Andrea Abbona

5 joint publications

Matteo Paccagnella